BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22429326)

  • 1. DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity.
    Kim HJ; Kim JH; Chie EK; Young PD; Kim IA; Kim IH
    Radiat Oncol; 2012 Mar; 7():39. PubMed ID: 22429326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
    Billam M; Sobolewski MD; Davidson NE
    Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression.
    Luszczek W; Cheriyath V; Mekhail TM; Borden EC
    Mol Cancer Ther; 2010 Aug; 9(8):2309-21. PubMed ID: 20682643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
    Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
    Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
    Chuang JC; Yoo CB; Kwan JM; Li TW; Liang G; Yang AS; Jones PA
    Mol Cancer Ther; 2005 Oct; 4(10):1515-20. PubMed ID: 16227400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly Synthesized DNA Methyltransferase Inhibitors as Radiosensitizers for Human Lung Cancer and Glioblastoma Cells.
    Wee CW; Kim JH; Kim HJ; Kang HC; Suh SY; Shin BS; Ma E; Kim IH
    Anticancer Res; 2021 Feb; 41(2):757-764. PubMed ID: 33517280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
    Nandakumar V; Vaid M; Katiyar SK
    Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors.
    Li A; Omura N; Hong SM; Goggins M
    Cancer Biol Ther; 2010 Feb; 9(4):321-9. PubMed ID: 20234167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
    Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
    J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells.
    Ruiz-Magaña MJ; Rodríguez-Vargas JM; Morales JC; Saldivia MA; Schulze-Osthoff K; Ruiz-Ruiz C
    Int J Cancer; 2012 Mar; 130(5):1195-207. PubMed ID: 21455989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.
    Flotho C; Claus R; Batz C; Schneider M; Sandrock I; Ihde S; Plass C; Niemeyer CM; Lübbert M
    Leukemia; 2009 Jun; 23(6):1019-28. PubMed ID: 19194470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of radiosensitization by YM155, a novel small molecule inhibitor of survivin expression, is associated with DNA damage repair.
    Hu S; Fu S; Xu X; Chen L; Xu J; Li B; Qu Y; Yu H; Lu S; Li W
    Cell Physiol Biochem; 2015; 37(3):1219-30. PubMed ID: 26418254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
    Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
    Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines.
    Stresemann C; Brueckner B; Musch T; Stopper H; Lyko F
    Cancer Res; 2006 Mar; 66(5):2794-800. PubMed ID: 16510601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.
    Champion C; Guianvarc'h D; Sénamaud-Beaufort C; Jurkowska RZ; Jeltsch A; Ponger L; Arimondo PB; Guieysse-Peugeot AL
    PLoS One; 2010 Aug; 5(8):e12388. PubMed ID: 20808780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage.
    Kang HC; Chie EK; Kim HJ; Kim JH; Kim IH; Kim K; Shin BS; Ma E
    Invest New Drugs; 2019 Dec; 37(6):1158-1165. PubMed ID: 30793218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
    Palii SS; Van Emburgh BO; Sankpal UT; Brown KD; Robertson KD
    Mol Cell Biol; 2008 Jan; 28(2):752-71. PubMed ID: 17991895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.
    Fan J; Yin WJ; Lu JS; Wang L; Wu J; Wu FY; Di GH; Shen ZZ; Shao ZM
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):883-90. PubMed ID: 18264725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.